Edition:
United States

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

1.10USD
3:59pm EST
Change (% chg)

$-0.05 (-4.35%)
Prev Close
$1.15
Open
$1.15
Day's High
$1.15
Day's Low
$1.10
Volume
58,791
Avg. Vol
125,897
52-wk High
$8.90
52-wk Low
$1.08

RGLS.OQ

Chart for RGLS.OQ

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.76
Market Cap(Mil.): $60.86
Shares Outstanding(Mil.): 52.92
Dividend: --
Yield (%): --

Financials

  RGLS.OQ Industry Sector
P/E (TTM): -- 47.00 29.32
EPS (TTM): -1.31 -- --
ROI: -59.58 -4.07 13.03
ROE: -69.55 4.71 14.17

BRIEF-Regulus Therapeutics announces continuation of RG-101 clinical hold

* Received written communication from FDA that clinical development program for RG-101 remains on clinical hold

Jan 27 2017

BRIEF-Regulus reports third quarter 2016 financial results

* Regulus reports third quarter 2016 financial results Source text for Eikon: Further company coverage:

Nov 01 2016

More From Around the Web

Competitors

Earnings vs. Estimates